Skip to content
- Teva Pharmaceutical (NYSE:TEVA) is scheduled to announce Q2 earnings results on Wednesday, July 30th, before market open.
- The consensus EPS Estimate is $0.62 (+1.6% Y/Y) and the consensus revenue estimate is $4.27B (+1.7% Y/Y).
- Over the last 2 years, TEVA has beaten EPS estimates 75% of the time and has beaten revenue estimates 100% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 4 downward. Revenue estimates have seen 1 upward revision and 3 downward.
More on Teva Pharmaceutical
